| Product Code: ETC11831685 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Cell Gene Therapy CDMO Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Cell Gene Therapy CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 China Cell Gene Therapy CDMO Market - Industry Life Cycle |
3.4 China Cell Gene Therapy CDMO Market - Porter's Five Forces |
3.5 China Cell Gene Therapy CDMO Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 China Cell Gene Therapy CDMO Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 China Cell Gene Therapy CDMO Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 China Cell Gene Therapy CDMO Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 China Cell Gene Therapy CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and targeted therapies |
4.2.2 Growing prevalence of chronic diseases driving the need for advanced treatment options |
4.2.3 Favorable government initiatives and policies supporting cell gene therapy development in China |
4.3 Market Restraints |
4.3.1 High costs associated with cell gene therapy development and manufacturing |
4.3.2 Regulatory challenges and compliance requirements impacting market entry and growth |
4.3.3 Limited expertise and infrastructure for cell gene therapy manufacturing in China |
5 China Cell Gene Therapy CDMO Market Trends |
6 China Cell Gene Therapy CDMO Market, By Types |
6.1 China Cell Gene Therapy CDMO Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 China Cell Gene Therapy CDMO Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 China Cell Gene Therapy CDMO Market Revenues & Volume, By Viral Vector Manufacturing, 2021 - 2031F |
6.1.4 China Cell Gene Therapy CDMO Market Revenues & Volume, By Plasmid DNA Manufacturing, 2021 - 2031F |
6.1.5 China Cell Gene Therapy CDMO Market Revenues & Volume, By Cell Therapy Manufacturing, 2021 - 2031F |
6.1.6 China Cell Gene Therapy CDMO Market Revenues & Volume, By Cryopreservation Services, 2021 - 2031F |
6.2 China Cell Gene Therapy CDMO Market, By Technology Type |
6.2.1 Overview and Analysis |
6.2.2 China Cell Gene Therapy CDMO Market Revenues & Volume, By Lentiviral Vector Technology, 2021 - 2031F |
6.2.3 China Cell Gene Therapy CDMO Market Revenues & Volume, By Plasmid-Based Gene Delivery, 2021 - 2031F |
6.2.4 China Cell Gene Therapy CDMO Market Revenues & Volume, By CAR-T Cell Expansion Technology, 2021 - 2031F |
6.2.5 China Cell Gene Therapy CDMO Market Revenues & Volume, By Controlled-Rate Freezing, 2021 - 2031F |
6.3 China Cell Gene Therapy CDMO Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 China Cell Gene Therapy CDMO Market Revenues & Volume, By Biopharmaceutical Companies, 2021 - 2031F |
6.3.3 China Cell Gene Therapy CDMO Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.3.4 China Cell Gene Therapy CDMO Market Revenues & Volume, By Hospitals and Clinics, 2021 - 2031F |
6.3.5 China Cell Gene Therapy CDMO Market Revenues & Volume, By Cell and Gene Therapy Developers, 2021 - 2031F |
6.4 China Cell Gene Therapy CDMO Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 China Cell Gene Therapy CDMO Market Revenues & Volume, By Gene Delivery for Cell Therapy, 2021 - 2031F |
6.4.3 China Cell Gene Therapy CDMO Market Revenues & Volume, By Preclinical and Clinical Studies, 2021 - 2031F |
6.4.4 China Cell Gene Therapy CDMO Market Revenues & Volume, By Oncology and Rare Diseases Treatment, 2021 - 2031F |
6.4.5 China Cell Gene Therapy CDMO Market Revenues & Volume, By Transport of Cell Therapies, 2021 - 2031F |
7 China Cell Gene Therapy CDMO Market Import-Export Trade Statistics |
7.1 China Cell Gene Therapy CDMO Market Export to Major Countries |
7.2 China Cell Gene Therapy CDMO Market Imports from Major Countries |
8 China Cell Gene Therapy CDMO Market Key Performance Indicators |
8.1 Number of partnerships and collaborations with academic institutions and research organizations |
8.2 Rate of adoption of innovative technologies in cell gene therapy manufacturing processes |
8.3 Number of successful clinical trials and regulatory approvals for cell gene therapies in China |
9 China Cell Gene Therapy CDMO Market - Opportunity Assessment |
9.1 China Cell Gene Therapy CDMO Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 China Cell Gene Therapy CDMO Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.3 China Cell Gene Therapy CDMO Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 China Cell Gene Therapy CDMO Market Opportunity Assessment, By Application, 2021 & 2031F |
10 China Cell Gene Therapy CDMO Market - Competitive Landscape |
10.1 China Cell Gene Therapy CDMO Market Revenue Share, By Companies, 2024 |
10.2 China Cell Gene Therapy CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here